October 2019 FDA Recall Lmd In Dextrose by Pfizer Inc.
D-0136-2020 - Lack of Assurance of Sterility
This Class II drug recall was voluntarily initiated by Pfizer Inc. on October 2, 2019 for the product Lmd In Dextrose. The FDA reported the reason for recall as lack of assurance of sterility. The product was distributed Nationwide and the recall is currently terminated.
Recall Number: D-0136-2020
Lack of Assurance of Sterility: Bag has the potential to leak.
10-02-2019
10-16-2019
17832 bags
Recall Profile & Regulatory Data
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
The firm responsible for the recall.
Pfizer Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
General area of initial distribution.
Nationwide in the United States and Puerto Rico
12-01-2020
Product Description About Product Description
Full technical description of the product.
Full technical description of the product.
10% LMD in 5% Dextrose Injection Dextran 40 in Dextrose Injection, USP, 500 mL bags, Rx only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-7418-13
Batch or Lot Expiration Information
Lot# : 87-095-JT Exp. 1MAR2020
